Yayoi Hayashi

999 total citations
39 papers, 817 citations indexed

About

Yayoi Hayashi is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Yayoi Hayashi has authored 39 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Yayoi Hayashi's work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (9 papers) and Folate and B Vitamins Research (6 papers). Yayoi Hayashi is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (9 papers) and Folate and B Vitamins Research (6 papers). Yayoi Hayashi collaborates with scholars based in Japan, United States and Sweden. Yayoi Hayashi's co-authors include Hiroaki Yuasa, Katsuhisa Inoue, Kinya Ohta, Jun Watanabe, Kikuo Iwamoto, Masaki Otagiri, Yasuhiro Nakai, Jeffrey L. Barnett, Gordon L. Amidon and Toyonori Kato and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and Pharmaceutical Research.

In The Last Decade

Yayoi Hayashi

39 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yayoi Hayashi Japan 17 269 197 179 143 117 39 817
Oxana Doroshyenko Germany 15 328 1.2× 274 1.4× 53 0.3× 106 0.7× 33 0.3× 18 1.1k
Sarah Shugarts United States 9 259 1.0× 130 0.7× 35 0.2× 119 0.8× 40 0.3× 13 691
Amanda Freeman United States 11 287 1.1× 177 0.9× 45 0.3× 73 0.5× 30 0.3× 13 748
Vikram Arya United States 18 479 1.8× 177 0.9× 40 0.2× 359 2.5× 70 0.6× 50 1.1k
J Catalin France 19 321 1.2× 297 1.5× 57 0.3× 95 0.7× 17 0.1× 61 1.0k
Yong–Hae Han United States 19 584 2.2× 378 1.9× 45 0.3× 307 2.1× 64 0.5× 39 1.3k
Peter R. Gwilt United States 17 207 0.8× 229 1.2× 24 0.1× 91 0.6× 22 0.2× 44 963
M Hroch Czechia 20 259 1.0× 198 1.0× 59 0.3× 60 0.4× 11 0.1× 70 1.0k
Klaus Kutz Switzerland 21 304 1.1× 297 1.5× 40 0.2× 434 3.0× 347 3.0× 59 1.8k
Joe Palandra United States 15 360 1.3× 282 1.4× 32 0.2× 183 1.3× 24 0.2× 25 838

Countries citing papers authored by Yayoi Hayashi

Since Specialization
Citations

This map shows the geographic impact of Yayoi Hayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yayoi Hayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yayoi Hayashi more than expected).

Fields of papers citing papers by Yayoi Hayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yayoi Hayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yayoi Hayashi. The network helps show where Yayoi Hayashi may publish in the future.

Co-authorship network of co-authors of Yayoi Hayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Yayoi Hayashi. A scholar is included among the top collaborators of Yayoi Hayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yayoi Hayashi. Yayoi Hayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohta, Kinya, et al.. (2015). Kinetic and time-dependent features of sustained inhibitory effect of myricetin on folate transport by proton-coupled folate transporter. Drug Metabolism and Pharmacokinetics. 30(5). 341–346. 3 indexed citations
2.
Inoue, Katsuhisa, et al.. (2014). Noncompetitive Inhibition of Proton-coupled Folate Transporter by Myricetin. Drug Metabolism and Pharmacokinetics. 29(4). 312–316. 8 indexed citations
3.
Inoue, Katsuhisa, et al.. (2014). Sustained inhibition of proton-coupled folate transporter by myricetin. Drug Metabolism and Pharmacokinetics. 30(2). 154–159. 9 indexed citations
4.
Inoue, Katsuhisa, et al.. (2013). Transcriptional regulation of PCFT by KLF4, HNF4α, CDX2 and C/EBPα: Implication in its site-specific expression in the small intestine. Biochemical and Biophysical Research Communications. 431(2). 158–163. 16 indexed citations
5.
Inoue, Katsuhisa, Yasuhiro Nakai, Kinya Ohta, et al.. (2008). Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model. American Journal of Physiology-Gastrointestinal and Liver Physiology. 294(3). G660–G668. 82 indexed citations
6.
Yuasa, Hiroaki, Katsuhisa Inoue, & Yayoi Hayashi. (2008). Molecular and Functional Characteristics of Proton-Coupled Folate Transporter. Journal of Pharmaceutical Sciences. 98(5). 1608–1616. 33 indexed citations
7.
Inoue, Katsuhisa, et al.. (2008). Effect of Glycerol-Related Compounds on Carrier-Mediated Glycerol Uptake in HCT-15 Human Colon Cancer Cell Line. Drug Metabolism and Pharmacokinetics. 23(3). 216–220. 4 indexed citations
8.
Inoue, Katsuhisa, et al.. (2007). Enhanced Uptake of Glycerol by Butyrate Treatment in HCT-15 Human Colon Cancer Cell Line. Drug Metabolism and Pharmacokinetics. 22(3). 195–198. 7 indexed citations
9.
Kato, Ryuji, Hiroaki Yuasa, Katsuhisa Inoue, et al.. (2007). Effect of Lactobacillus casei on the Absorption of Nifedipine from Rat Small Intestine. Drug Metabolism and Pharmacokinetics. 22(2). 96–102. 16 indexed citations
10.
Inoue, Katsuhisa, et al.. (2006). Glycerol Uptake in HCT-15 Human Colon Cancer Cell Line by Na+-Dependent Carrier-Mediated Transport. Biological and Pharmaceutical Bulletin. 29(1). 150–154. 17 indexed citations
11.
Kato, Toyonori, Yayoi Hayashi, Katsuhisa Inoue, & Hiroaki Yuasa. (2005). Glycerol Absorption by Na+-Dependent Carrier-Mediated Transport in the Closed Loop of the Rat Small Intestine. Biological and Pharmaceutical Bulletin. 28(3). 553–555. 25 indexed citations
12.
Uchida, Kazuharu, et al.. (2004). Dose Adjustment Strategy for Oral Microemulsion Formulation of Cyclosporine. Therapeutic Drug Monitoring. 26(3). 287–294. 14 indexed citations
13.
Nakamura, Takatoshi, Hiroaki Yuasa, Katsuhisa Inoue, Yayoi Hayashi, & Jun Watanabe. (2002). Effect of Maleylated Bovine Serum Albumin on the Disposition of Fractionated Heparin in Rats. 62(3). 81–86. 1 indexed citations
14.
Welage, Lynda S., Yayoi Hayashi, Jeffrey L. Barnett, et al.. (2002). Variability in cimetidine absorption and plasma double peaks following oral administration in the fasted state in humans: correlation with antral gastric motility. European Journal of Pharmaceutics and Biopharmaceutics. 53(1). 37–47. 38 indexed citations
15.
Iwao, Takahiro, Katsuhisa Inoue, Yayoi Hayashi, Hiroaki Yuasa, & Jun Watanabe. (2002). Metabolic Extraction of Nifedipine during Absorption from the Rat Small Intestine. Drug Metabolism and Pharmacokinetics. 17(6). 546–553. 28 indexed citations
16.
Welage, Lynda S., Nasir Idkaidek, Yayoi Hayashi, et al.. (2001). Human Jejunal Permeability of Two Polar Drugs: Cimetidine and Ranitidine. Pharmaceutical Research. 18(6). 742–744. 50 indexed citations
17.
Welage, Lynda S., Nasir Idkaidek, Dantong Liu, et al.. (1997). Human Intestinal Permeability of Piroxicam, Propranolol, Phenylalanine, and PEG 400 Determined by Jejunal Perfusion. Pharmaceutical Research. 14(9). 1127–1132. 41 indexed citations
18.
Aoki, Koji, et al.. (1993). Specific Antiphospholipid Antibodies as a Predictive Variable in Patients With Recurrent Pregnancy Loss. American Journal of Reproductive Immunology. 29(2). 82–87. 40 indexed citations
19.
Hayashi, Yayoi, Jun Watanabe, Shoji Ozeki, & Kikuo Iwamoto. (1988). Salivary excretion of 5-fluorouracil(5-FU). III. Non-linear kinetics of salivary excretion of 5-FU following bolus intravenous administration in rats.. Chemical and Pharmaceutical Bulletin. 36(11). 4547–4553. 8 indexed citations
20.
Watanabe, Jun, et al.. (1985). Mandibular and Parotid Salivary Levels of Indomethacin Following Intravenous Administration to Rabbits. Pharmaceutical Research. 2(4). 185–187. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oxana Doroshyenko Breakdown of academic impact, for papers by Sarah Shugarts Breakdown of academic impact, for papers by Amanda Freeman Breakdown of academic impact, for papers by Vikram Arya Breakdown of academic impact, for papers by J Catalin Breakdown of academic impact, for papers by Yong–Hae Han Breakdown of academic impact, for papers by Peter R. Gwilt Breakdown of academic impact, for papers by M Hroch Breakdown of academic impact, for papers by Klaus Kutz Breakdown of academic impact, for papers by Joe Palandra
Rankless by CCL
2026